New discoveries in the molecular landscape of bladder cancer

Ashish M. Kamat, Roger Li, Woonyoung Choi, J. E. Ferguson, Michael J. Metcalfe

Research output: Contribution to journalReview article

Abstract

We are currently on the cusp of exponential growth in the understanding of the molecular landscape of bladder cancer. Emerging data regarding the mutational burden and targetable genomic and protein alterations in bladder cancer have allowed us to tap into treatments directed toward specific molecular characteristics of bladder cancer. In parallel, these developments will enable us to better select patients for existing treatments of bladder cancer in a step toward personalized therapy. The present article reviews select discoveries that have advanced our understanding of bladder cancer and gives a glimpse of the exciting opportunities on the not-so-distant horizon.

Original languageEnglish (US)
Article number2875
JournalF1000Research
Volume5
DOIs
StatePublished - Jan 1 2016
Externally publishedYes

Fingerprint

Urinary Bladder Neoplasms
Proteins
Therapeutics
Growth

Keywords

  • Bladder
  • Carcinoma
  • Genomics
  • Sequencing

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

New discoveries in the molecular landscape of bladder cancer. / Kamat, Ashish M.; Li, Roger; Choi, Woonyoung; Ferguson, J. E.; Metcalfe, Michael J.

In: F1000Research, Vol. 5, 2875, 01.01.2016.

Research output: Contribution to journalReview article

Kamat, Ashish M. ; Li, Roger ; Choi, Woonyoung ; Ferguson, J. E. ; Metcalfe, Michael J. / New discoveries in the molecular landscape of bladder cancer. In: F1000Research. 2016 ; Vol. 5.
@article{60869c95643f4c7e9ace94997ec095df,
title = "New discoveries in the molecular landscape of bladder cancer",
abstract = "We are currently on the cusp of exponential growth in the understanding of the molecular landscape of bladder cancer. Emerging data regarding the mutational burden and targetable genomic and protein alterations in bladder cancer have allowed us to tap into treatments directed toward specific molecular characteristics of bladder cancer. In parallel, these developments will enable us to better select patients for existing treatments of bladder cancer in a step toward personalized therapy. The present article reviews select discoveries that have advanced our understanding of bladder cancer and gives a glimpse of the exciting opportunities on the not-so-distant horizon.",
keywords = "Bladder, Carcinoma, Genomics, Sequencing",
author = "Kamat, {Ashish M.} and Roger Li and Woonyoung Choi and Ferguson, {J. E.} and Metcalfe, {Michael J.}",
year = "2016",
month = "1",
day = "1",
doi = "10.12688/f1000research.10031.1",
language = "English (US)",
volume = "5",
journal = "F1000Research",
issn = "2046-1402",
publisher = "F1000 Research Ltd.",

}

TY - JOUR

T1 - New discoveries in the molecular landscape of bladder cancer

AU - Kamat, Ashish M.

AU - Li, Roger

AU - Choi, Woonyoung

AU - Ferguson, J. E.

AU - Metcalfe, Michael J.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - We are currently on the cusp of exponential growth in the understanding of the molecular landscape of bladder cancer. Emerging data regarding the mutational burden and targetable genomic and protein alterations in bladder cancer have allowed us to tap into treatments directed toward specific molecular characteristics of bladder cancer. In parallel, these developments will enable us to better select patients for existing treatments of bladder cancer in a step toward personalized therapy. The present article reviews select discoveries that have advanced our understanding of bladder cancer and gives a glimpse of the exciting opportunities on the not-so-distant horizon.

AB - We are currently on the cusp of exponential growth in the understanding of the molecular landscape of bladder cancer. Emerging data regarding the mutational burden and targetable genomic and protein alterations in bladder cancer have allowed us to tap into treatments directed toward specific molecular characteristics of bladder cancer. In parallel, these developments will enable us to better select patients for existing treatments of bladder cancer in a step toward personalized therapy. The present article reviews select discoveries that have advanced our understanding of bladder cancer and gives a glimpse of the exciting opportunities on the not-so-distant horizon.

KW - Bladder

KW - Carcinoma

KW - Genomics

KW - Sequencing

UR - http://www.scopus.com/inward/record.url?scp=85010886962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010886962&partnerID=8YFLogxK

U2 - 10.12688/f1000research.10031.1

DO - 10.12688/f1000research.10031.1

M3 - Review article

AN - SCOPUS:85010886962

VL - 5

JO - F1000Research

JF - F1000Research

SN - 2046-1402

M1 - 2875

ER -